Alpha‐Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation via Wnt‐Hippo Signaling. Issue 10 (20th March 2022)
- Record Type:
- Journal Article
- Title:
- Alpha‐Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation via Wnt‐Hippo Signaling. Issue 10 (20th March 2022)
- Main Title:
- Alpha‐Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation via Wnt‐Hippo Signaling
- Authors:
- Si, Xuemeng
Jia, Hai
Liu, Ning
Li, Jun
Pan, Lina
Wang, Jiaqi
Wu, Zhenlong - Abstract:
- Abstract : Scope: Inflammatory bowel disease is an inflammatory gastrointestinal disorder associated with intestinal barrier damage, cell proliferation disorder, and dysbiosis of the intestinal microbiota. It remains unknown whether alpha‐ketoglutarate (α‐KG) can alleviate colitis in mice. Methods and results: Six‐week‐old male C57BL/6 mice supplemented with or without 0.5% α‐KG (delivered in the form of sodium salt) are subjected to drinking water or 2.5% DSS to induce colitis. The results show that α‐KG administration is attenuated the severity of colitis, as is indicated by reduced body‐weight loss, colon shortening and colonic hyperplasia, and repressed proinflammatory cytokine secretion in DSS‐challenged mice. Additionally, DSS‐induced increases in malondialdehyde (MDA) and hydrogen peroxide (H2 O2 ), and decreases in glutathione (GSH) levels are attenuated by α‐KG administration. Further study shows that the protective effect of α‐KG is associated with restoring gut barrier integrity by enhancing the expression of tight junction proteins, increasing Lactobacillus levels, and regulating gut hyperplasia by the Wnt‐Hippo signaling pathway in DSS‐induced colitis. Conclusion: Collectively, the data provided herein demonstrate that α‐KG administration is attenuated mucosal inflammation, barrier dysfunction, and gut microflora dysbiosis. This beneficial effect is associated with increased Lactobacillus levels and regulated colon hyperplasia by the Wnt‐Hippo signaling pathway.Abstract : Scope: Inflammatory bowel disease is an inflammatory gastrointestinal disorder associated with intestinal barrier damage, cell proliferation disorder, and dysbiosis of the intestinal microbiota. It remains unknown whether alpha‐ketoglutarate (α‐KG) can alleviate colitis in mice. Methods and results: Six‐week‐old male C57BL/6 mice supplemented with or without 0.5% α‐KG (delivered in the form of sodium salt) are subjected to drinking water or 2.5% DSS to induce colitis. The results show that α‐KG administration is attenuated the severity of colitis, as is indicated by reduced body‐weight loss, colon shortening and colonic hyperplasia, and repressed proinflammatory cytokine secretion in DSS‐challenged mice. Additionally, DSS‐induced increases in malondialdehyde (MDA) and hydrogen peroxide (H2 O2 ), and decreases in glutathione (GSH) levels are attenuated by α‐KG administration. Further study shows that the protective effect of α‐KG is associated with restoring gut barrier integrity by enhancing the expression of tight junction proteins, increasing Lactobacillus levels, and regulating gut hyperplasia by the Wnt‐Hippo signaling pathway in DSS‐induced colitis. Conclusion: Collectively, the data provided herein demonstrate that α‐KG administration is attenuated mucosal inflammation, barrier dysfunction, and gut microflora dysbiosis. This beneficial effect is associated with increased Lactobacillus levels and regulated colon hyperplasia by the Wnt‐Hippo signaling pathway. Abstract : DSS‐induced colitis is associated with epithelial cell hyperplasia and perturbations of gut flora. This detrimental effect can be attenuated by alpha‐ketoglutarate through suppressing the Wnt‐Hippo signaling and strengthening the enrichment of Lactobacillus and diminishment of Turicibacter . Supplementation with alpha‐ketoglutarate is a nutritional strategy to alleviate inflammatory colon injury in mice. … (more)
- Is Part Of:
- Molecular nutrition & food research. Volume 66:Issue 10(2022)
- Journal:
- Molecular nutrition & food research
- Issue:
- Volume 66:Issue 10(2022)
- Issue Display:
- Volume 66, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 66
- Issue:
- 10
- Issue Sort Value:
- 2022-0066-0010-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-03-20
- Subjects:
- alpha‐ketoglutarate -- DSS‐induced colitis -- intestinal stem cell -- Lactobacillus -- Wnt/β‐catenin‐Hippo signaling
Food -- Biotechnology -- Periodicals
Food -- Microbiology -- Periodicals
Nutrition -- Periodicals
Food -- Toxicology -- Periodicals
Nutrition -- Periodicals
Food Microbiology -- Periodicals
Food Technology -- Periodicals
Molecular Biology -- Periodicals
664.0705 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/mnfr.202100955 ↗
- Languages:
- English
- ISSNs:
- 1613-4125
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817992
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21575.xml